If you create a chatbot, you don't want screenshots of it on X helping you to commit suicide or giving itself weird nicknames based on dubious historic figures. I think that's probably the use-case for this kind of research.
Yes, that's what I meant by companies doing this to cover their asses, but then again, why should presumably independent researchers be so scared of that to the point of not even releasing a mild working example.
Furthermore, using poetry as a jailbreak technique is very obvious, and if you blame a LLM for responding to such an obvious jailbreak, you may as well blame Photoshop for letting people make porn fakes. It is very clear that the intent comes from the user, not from the tool. I understand why companies want to avoid that, I just don't think it is that big a deal. Public opinion may differ though.
> The easiest way to get MyGNUHealth is by installing the package from your favorite operating system / distribution. Many operating system distributions already ship MyGNUHealth.
I was actually curious to try this out on my phone, since they claim to support mobile devices.
If running a command-line package manager is the easiest way to install this on Android, I don't want to know what harder ways exist.
I find this is quite typical for open source projects. The community still hasn't really, truly adopted mobile. I guess it's because of the need to have some sort of entity be present in the various App Stores? But if it's possible for servers, why is this so rare to have open source projects as app store vendors?
> I guess it's because of the need to have some sort of entity be present in the various App Stores?
This, and the fees, and dealing with weird App stores' rules. On Android, we had F-Droid - an alternative store where one didn't need to deal with this. And as has been reported recently, Google is making changes that will essentially kill F-Droid.
The reason there's not much good open source stuff on phones compared to PCs is because the hardware is hostile to it. The few phones out there that aren't are the ones almost no one uses.
You seem to be living in the past. While EHRs are still primarily used from desktop PCs, all of the major ones have native mobile apps now. Clinicians appreciate being able to review patient charts and action alerts while away from a PC cart.
And this would be a white-label Epic MyChart for the particular system with embedding for the inpatient or customer facing connections that should be used
It seems like that could be done with a system shipping their own white-labeled GNU Health app through the App Store
You're really missing the point. The EHR vendors aren't charging customers for those apps through the Apple or Google app stores so "broken economics" are irrelevant. The app stores are only a distribution mechanism and work fine for that.
There is something to be said for trust here. I like that I can go straight to the imprint ("Impressum") to know with whom I'm dealing with online, where the company is located and who the CEO is. This is not always easy to decipher from the "Terms" pages companies in the US and elsewhere provide.
The downside for founders is that you have to divulge your address, unless you take additional steps to give yourself a mailbox address, but this can also be illegal if you're not careful. You can also rent an office of course, but for indie devs and freelancers, this is usually not financially viable.
That's a bit exaggerated. I did have a company, and while it did come with bureaucracy, the vast majority of my time was spent on what you expect a founder to do (sales, marketing, product, etc.).
Not OP, but we've had variations of "let's get a bunch of people together for a party" since the Stone Age. Meeting and events became a formal "industry" only a few decades ago. But meetings and events themselves are as Lindy as prostitution and war.
The guy got sick with a mystery illness didn't he? This was about 20 years ago. He blogged about the saga of having doctors try to figure out what was wrong with him, and I think was self-administering various treatments. Must look up how he's doing.
This very technique is why I loved Salman Khan's teaching videos on Khan Academy so much. On any topic, he goes straight to the content, no intro whatsoever.
Performance on mobile devices and UI libraries. Avalonia ecosystem is predominantly focused on desktop, which is not the case for Uno. But I liked the fact that setting up and AOT compiling Avalonia templates was a breeze so use it for side projects. For something more serious that has to target mobile, I would investigate how much MAUI has progressed in terms of quality and if problematic, would just go with Uno.
Quite. It sounds like they only got there in the first place because normally astronauts are given half their bodyweight in antibiotics to prevent exactly this from happening. And it did. Except for the drug resistant ones.
Question is: will it mutate into something which is no longer drug resistant? And is there any compelling reason for it to do so?
Of all the strains of bacteria that we might give an opportunity to optimize for space survival, why would we pick something that is a threat to humans.
Space travel involves humans in an inescapable environment, without access to many medical therapies, and with potentially compromises immune systems! [0]
Seems like a strange choice.
Future news: "Drug resistant bacteria impossible to purge from Starship Mars Flyby 1. Sick astronauts turn strange color, sweat strange substance. Want to come home, but have 90% of their journey ahead. Fearing their novel infection, NASA tells them "Don't come back!", sends them erroneous course corrections. Bacteria researchers from 2024 experiment, jubilant at this dramatic evidence of their success, request more funding and astronauts."
> Of all the strains of bacteria that we might give an opportunity to optimize for space survival, why would we pick something that is a threat to humans.
These bacteria were not intentionally brought to the ISS, they hitched a ride in/on the crews and colonized the station. From the paper [1]:
We obtained 211 assembled genomes, annotated as E. bugandensis, from the publicly available National Center for Biotechnology Information’s (NCBI) GenBank sequence database [20]. Among these genomes, 12 were isolated from three different locations aboard the ISS during the first Flight of the MT-1 mission: four from the Air Control (AC) samples, one from the Advanced Resistive Exercise Device (ARED), and seven from the Waste and Hygiene Compartment (WHC). Additionally, one metagenome-assembled genome (MAG) was recovered from the WHC samples.
Well, we can either pretend it didn't happen and ignore it, or do the opposite and study it well so that one day we understand what makes them so efficient at dealing with X rays and existing drugs.
I mean they're studying the bacteria, not "optimizing them for space travel".
And... the bacteria which are a threat to humans are exactly the ones we are interested in studying, because knowing more about them helps us figure out how to make them be less of a threat to humans.
